These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 12011805)
21. Application of four dyes in gene expression analyses by microarrays. Staal YC; van Herwijnen MH; van Schooten FJ; van Delft JH BMC Genomics; 2005 Jul; 6():101. PubMed ID: 16042794 [TBL] [Abstract][Full Text] [Related]
22. Performance characteristics of 65-mer oligonucleotide microarrays. Lee M; Xiang CC; Trent JM; Bittner ML Anal Biochem; 2007 Sep; 368(1):70-8. PubMed ID: 17617369 [TBL] [Abstract][Full Text] [Related]
23. Processing the loblolly pine PtGen2 cDNA microarray. Lorenz WW; Yu YS; Simões M; Dean JF J Vis Exp; 2009 Mar; (25):. PubMed ID: 19305380 [TBL] [Abstract][Full Text] [Related]
24. DNA microarrays: sample quality control, array hybridization and scanning. Diaz E; Barisone GA J Vis Exp; 2011 Mar; (49):. PubMed ID: 21445042 [TBL] [Abstract][Full Text] [Related]
25. Automation of cDNA microarray hybridization and washing yields improved data quality. Yauk C; Berndt L; Williams A; Douglas GR J Biochem Biophys Methods; 2005 Jul; 64(1):69-75. PubMed ID: 16005076 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of amplified cRNA targets for oligonucleotide microarrays. Sawada A; Mizufune S; Kaji N; Tokeshi M; Baba Y Anal Bioanal Chem; 2007 Apr; 387(8):2645-54. PubMed ID: 17285305 [TBL] [Abstract][Full Text] [Related]
27. Monitoring gene expression profile changes in bladder transitional cell carcinoma using cDNA microarray. Ying-Hao S; Qing Y; Lin-Hui W; Li G; Rong T; Kang Y; Chuan-Liang X; Song-Xi Q; Yao L; Yi X; Yu-Ming M Urol Oncol; 2002; 7(5):207-12. PubMed ID: 12644218 [TBL] [Abstract][Full Text] [Related]
28. [Construction and primary application of oligonucleotide microarray specialized for pancreatic adenocarcinoma-associated genes]. Shi X; Wei WJ; Gao NR; Cheng ZJ; Tang YH Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(1):39-42. PubMed ID: 17403288 [TBL] [Abstract][Full Text] [Related]
30. A qualitative assessment of direct-labeled cDNA products prior to microarray analysis. Grissom SF; Lobenhofer EK; Tucker CJ BMC Genomics; 2005 Mar; 6():36. PubMed ID: 15762992 [TBL] [Abstract][Full Text] [Related]
31. Development and validation of a method for using breast core needle biopsies for gene expression microarray analyses. Ellis M; Davis N; Coop A; Liu M; Schumaker L; Lee RY; Srikanchana R; Russell CG; Singh B; Miller WR; Stearns V; Pennanen M; Tsangaris T; Gallagher A; Liu A; Zwart A; Hayes DF; Lippman ME; Wang Y; Clarke R Clin Cancer Res; 2002 May; 8(5):1155-66. PubMed ID: 12006532 [TBL] [Abstract][Full Text] [Related]
32. Universal Reference RNA as a standard for microarray experiments. Novoradovskaya N; Whitfield ML; Basehore LS; Novoradovsky A; Pesich R; Usary J; Karaca M; Wong WK; Aprelikova O; Fero M; Perou CM; Botstein D; Braman J BMC Genomics; 2004 Mar; 5(1):20. PubMed ID: 15113400 [TBL] [Abstract][Full Text] [Related]
33. An alternative method to amplify RNA without loss of signal conservation for expression analysis with a proteinase DNA microarray in the ArrayTube format. Schüler S; Wenz I; Wiederanders B; Slickers P; Ehricht R BMC Genomics; 2006 Jun; 7():144. PubMed ID: 16768788 [TBL] [Abstract][Full Text] [Related]
34. DNA-microarray technology: comparison of methodological factors of recent technique towards gene expression profiling. Muyal JP; Singh SK; Fehrenbach H Crit Rev Biotechnol; 2008; 28(4):239-51. PubMed ID: 19051103 [TBL] [Abstract][Full Text] [Related]